AIMA Biotech

AIMA Biotech provides intestinal microbiota analysis and digital tools for healthcare professionals, researchers, clinics, and laboratories. Its services are intended for professional use and are not sold directly to the general public. Practitioners can choose from three testing options: bacterial analysis using 16S sequencing, bacterial and archaeal analysis, or shotgun metagenomic testing, which examines a broader range of microbial groups and functional potential.

Based on stool samples, AIMA’s testing assesses microbial composition, diversity, and associated functions. Results are delivered through an online platform and can be organized into customizable reports, including AI-assisted summaries that professionals can review and edit. The platform also supports case registration, patient follow-up, and comparison of microbiome changes over time, helping practitioners integrate findings with other clinical information. AIMA emphasizes carefully designed sampling processes, laboratory experience, scientific oversight, and support for complex cases. The company also offers professional training and opportunities to participate in scientific projects. Its analyses describe the microbiota and are not diagnostic; interpretation and healthcare decisions remain the responsibility of the treating professional.